Diagnosis of SLE made at least 6 months prior to Screening.
II/III - A combination of phases: (2) Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied. and (3) Research Studies that gather more information about a drug's safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs. These studies typically involve more participants.
University of Colorado Hospital
Christopher Striebich, MD, PhD
Protocol Number: 18-2346
More information available at ClinicalTrials.gov: NCT03742037
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers